Article Commentary: Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
Randomized clinical trials (RCTs) with first- and second-generation drug-eluting stents (DESs) confirmed the superiority of coronary artery bypass surgery (CABG) in patients with multiple vessel disease. In spite of different DES designs, investigators in these trials used similar percutaneous coron...
Main Authors: | Alfredo E. Rodriguez, Hernán Pavlovsky, Juan Francisco Del Pozo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | https://doi.org/10.4137/CMC.S40645 |
Similar Items
-
Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
by: Alfredo E. Rodriguez, et al.
Published: (2016-12-01) -
Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
by: Xue Chen, et al.
Published: (2020-01-01) -
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease
by: Kyriacos Papadopoulos, et al.
Published: (2017-01-01) -
Features of Cardiopulmonary Bypass in Mininvasive Multivessel Coronary Artery Bypass Grafting
by: V. M. Demianenko, et al.
Published: (2019-05-01) -
Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes
by: Kanaiya Panchal, et al.
Published: (2012-01-01)